Home>News & Events>Publications>C-Path>Towards Consensus Practices to Qualify Safety Biomarkers for Use in Early Drug Development86,56
May 10, 2010 PRINT PDF
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
What Evidence Do We Need for Biomarker Qualification?
Preclinical Biomarker Qualification
Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories
Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats